Cargando…
Comments on “Whole lung irradiation as a novel treatment for COVID-19: Interim results of an ongoing phase 2 trial in India”
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653397/ https://www.ncbi.nlm.nih.gov/pubmed/34896158 http://dx.doi.org/10.1016/j.radonc.2021.12.002 |
| _version_ | 1784611656351875072 |
|---|---|
| author | Ghaznavi, Hamid Bevelacqua, Joseph J. Mortazavi, S.A.R. Mortazavi, S.M.J. Welsh, James S. |
| author_facet | Ghaznavi, Hamid Bevelacqua, Joseph J. Mortazavi, S.A.R. Mortazavi, S.M.J. Welsh, James S. |
| author_sort | Ghaznavi, Hamid |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8653397 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier B.V. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86533972021-12-08 Comments on “Whole lung irradiation as a novel treatment for COVID-19: Interim results of an ongoing phase 2 trial in India” Ghaznavi, Hamid Bevelacqua, Joseph J. Mortazavi, S.A.R. Mortazavi, S.M.J. Welsh, James S. Radiother Oncol Letter to the Editor Elsevier B.V. 2022-02 2021-12-08 /pmc/articles/PMC8653397/ /pubmed/34896158 http://dx.doi.org/10.1016/j.radonc.2021.12.002 Text en © 2021 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Ghaznavi, Hamid Bevelacqua, Joseph J. Mortazavi, S.A.R. Mortazavi, S.M.J. Welsh, James S. Comments on “Whole lung irradiation as a novel treatment for COVID-19: Interim results of an ongoing phase 2 trial in India” |
| title | Comments on “Whole lung irradiation as a novel treatment for COVID-19: Interim results of an ongoing phase 2 trial in India” |
| title_full | Comments on “Whole lung irradiation as a novel treatment for COVID-19: Interim results of an ongoing phase 2 trial in India” |
| title_fullStr | Comments on “Whole lung irradiation as a novel treatment for COVID-19: Interim results of an ongoing phase 2 trial in India” |
| title_full_unstemmed | Comments on “Whole lung irradiation as a novel treatment for COVID-19: Interim results of an ongoing phase 2 trial in India” |
| title_short | Comments on “Whole lung irradiation as a novel treatment for COVID-19: Interim results of an ongoing phase 2 trial in India” |
| title_sort | comments on “whole lung irradiation as a novel treatment for covid-19: interim results of an ongoing phase 2 trial in india” |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653397/ https://www.ncbi.nlm.nih.gov/pubmed/34896158 http://dx.doi.org/10.1016/j.radonc.2021.12.002 |
| work_keys_str_mv | AT ghaznavihamid commentsonwholelungirradiationasanoveltreatmentforcovid19interimresultsofanongoingphase2trialinindia AT bevelacquajosephj commentsonwholelungirradiationasanoveltreatmentforcovid19interimresultsofanongoingphase2trialinindia AT mortazavisar commentsonwholelungirradiationasanoveltreatmentforcovid19interimresultsofanongoingphase2trialinindia AT mortazavismj commentsonwholelungirradiationasanoveltreatmentforcovid19interimresultsofanongoingphase2trialinindia AT welshjamess commentsonwholelungirradiationasanoveltreatmentforcovid19interimresultsofanongoingphase2trialinindia |